Europe - Euronext Amsterdam - AMS:DSFIR - CH1216478797 - Common Stock
The current stock price of DSFIR.AS is 71.22 EUR. In the past month the price decreased by -5.07%. In the past year, price decreased by -31.49%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.29B | ||
| SY1.DE | SYMRISE AG | 19.35 | 9.82B | ||
| AKU1.DE | AKZO NOBEL N.V. | 14.9 | 9.27B | ||
| AKZA.AS | AKZO NOBEL N.V. | 14.81 | 9.22B | ||
| SYENS.BR | SYENSQO SA | 21.3 | 7.19B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.64 | 6.11B | ||
| AKE.PA | ARKEMA | 9.99 | 3.91B | ||
| UMI.BR | UMICORE | 12.95 | 3.60B | ||
| NVJP.DE | UMICORE | 12.78 | 3.56B | ||
| WCH.DE | WACKER CHEMIE AG | 157.33 | 3.53B | ||
| RBT.PA | ROBERTET SA | 19.28 | 1.96B | ||
| ACT.DE | ALZCHEM GROUP AG | 20.95 | 1.30B |
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
DSM-FIRMENICH AG
Wurmisweg 576, Kaiseraugst
Kaiseraugst AARGAU CH
Employees: 28608
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
The current stock price of DSFIR.AS is 71.22 EUR. The price increased by 0.11% in the last trading session.
DSM-FIRMENICH AG (DSFIR.AS) has a dividend yield of 3.59%. The yearly dividend amount is currently 0.
DSFIR.AS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
30 analysts have analysed DSFIR.AS and the average price target is 104.09 EUR. This implies a price increase of 46.16% is expected in the next year compared to the current price of 71.22.
The Revenue of DSM-FIRMENICH AG (DSFIR.AS) is expected to decline by -0.86% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
DSM-FIRMENICH AG (DSFIR.AS) has a market capitalization of 18.92B EUR. This makes DSFIR.AS a Large Cap stock.
ChartMill assigns a fundamental rating of 3 / 10 to DSFIR.AS. DSFIR.AS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months DSFIR.AS reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS decreased by -89.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.95% | ||
| ROA | 0.77% | ||
| ROE | 1.17% | ||
| Debt/Equity | 0.24 |
30 analysts have analysed DSFIR.AS and the average price target is 104.09 EUR. This implies a price increase of 46.16% is expected in the next year compared to the current price of 71.22.
For the next year, analysts expect an EPS growth of 19.53% and a revenue growth -0.86% for DSFIR.AS